Keep out of reach of younger children
Its ease of use and demonstrated efficacy have earned it approval for both obesity treatment and type 2 diabetes management
The starting dose is intentionally low to build tolerance glucagon receptor activation is modest at this level
in: PubMed | Google Scholar | 1 Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA
Similarly, the substudy of the obesity phase 2 trial showed clear promise for retatrutide in the treatment of MASLD [47], and through its GCG receptor agonism, retatrutide may offer benefits beyond WL, through weight-independent metabolic effects at the liver [40]
How GLP-1 Helps You Lose Weight